Voyageur Pharmaceuticals (CVE:VM) Stock Price Up 21.2% – What’s Next?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) rose 21.2% during mid-day trading on Thursday . The stock traded as high as C$0.21 and last traded at C$0.20. Approximately 292,294 shares changed hands during mid-day trading, a decline of 46% from the average daily volume of 537,892 shares. The stock had previously closed at C$0.17.

Voyageur Pharmaceuticals Price Performance

The stock has a 50 day moving average of C$0.10 and a 200-day moving average of C$0.07. The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17. The company has a market cap of C$27.89 million, a PE ratio of -20.00 and a beta of 0.32.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Featured Stories

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.